[CH2:1]([C:4]1[N:9]=[C:8]2[S:10][C:11]([CH2:13][O:14][C:15]3[C:16]([F:25])=[C:17]([C:21]([F:24])=[CH:22][CH:23]=3)[C:18]([NH2:20])=[O:19])=[N:12][C:7]2=[CH:6][CH:5]=1)[CH:2]=[CH2:3]>CO.[Pd]>[F:25][C:16]1[C:15]([O:14][CH2:13][C:11]2[S:10][C:8]3[C:7]([N:12]=2)=[CH:6][CH:5]=[C:4]([CH2:1][CH2:2][CH3:3])[N:9]=3)=[CH:23][CH:22]=[C:21]([F:24])[C:17]=1[C:18]([NH2:20])=[O:19]To a solution of 3-(5-Allyl-thiazolo[5,4-b]pyridin-2-ylmethoxy)-2,6-difluoro-benzamide (0.018 g, 0.049 mmol) in 5 ml of anhydrous methanol was added Pd—C (10%, 5 mg) and the reaction mixture was stirred at 25° C. for 12 h under hydrogen atmosphere. The reaction mixture was filtered over the bed of celite and the filtrate was evaporated to dryness under reduced pressure to give the title compound as white solid (0.0078 g, 43%). 1H NMR (DMSO-d6, 400 MHz); δ 0.91 (m, 3H), 1.65 (m, 2H), 2.74 (m, 2H), 5.69 (s, 2H), 7.12 (m, 1H), 7.39 (m, 1H), 7.90 (br s, 1H), 8.18 (br s, 1H), 8.27 (br s, 1H) and 8.52 (br s, 1H). MS ES+(364.11), HPLC (method I) Rt=15.85 min.